I have previously posted on changes in the medical device clinical trial landscape noted at the MassMEDIC Annual Conference held May 7th at UMass Boston. Another area of discussion focused on financing emerging medical device companies. It is no secret … Continue reading
Category Archives: The Law
The medical device marketplace is all about FDA clinical trials, determining whether a device creates good patient outcomes and is reimbursable, and the avoidance of economic risk. These factors, interestingly, bear in a significant way on the manner in which … Continue reading
In the political, religious and cultural battles fought out before the United States Supreme Court these days, sometimes the cases that do not reach the court have the greatest impact. Steve Shapiro, Chief Counsel for the American Civil Liberties Union, … Continue reading
Yesterday I posted about remarks from Keith Higgins, head of CorpFin at the SEC, concerning general solicitation in securities placements for private companies. Higgins also discussed SEC changes being considered in the definiton of Accredited Investor (that class of people … Continue reading
Keith Higgins, recently an SEC lawyer here in Boston, and now Director of the Corporate Finance Division of the SEC (“Corp Fin”), addressed the Angel Capital Association in Washington last week, touching upon several matters affecting angel investors. Interestingly, he … Continue reading
Harry Broadman, PWC’s Chief Economist and leader of its emerging markets practice, makes an overwhelming case that the economic future of the world lies in the Far East, including but not limited to China and India (which between them have … Continue reading
At this morning’s meeting of New England Chapter National Association of Corporate Directors, a panel of experts struggled to define issues that directors should be worrying about today – issues which might not arise until 2015 or thereafter. The list of … Continue reading
We are moving into yet another “Congressional year” where deadlock must remain the anticipated norm. However, both the President’s budget and the Republican tax proposals contain corporate tax changes designed to drive different parts of the economy. Below (with thanks … Continue reading
Venture capital support for early stage businesses in Massachusetts, at least in the life sciences and in internet software, has not been this robust for many years. Such was the consensus of a panel of three Boston-based early stage venture … Continue reading
It is rare for a group of directors, such as the National Association of Corporate Directors/New England, to invite into its midst a so-called “activist shareholder.” At the February 11th breakfast meeting, however, the group was addressed by Gregory Taxin, … Continue reading